References
- Kuan Y-H, Shyu B-C. Nociceptive transmission and modulation via P2X receptors in central pain syndrome. Mol Brain. 2016;9(1):58. doi:10.1186/s13041-016-0240-4.
- Canavero S, Bonicalzi V. Extradural cortical stimulation for central pain. Acta Neurochir Suppl. 2007;97(Pt 2):27–36. doi:10.1007/978-3-211-33081-4_3.
- Noppers I, Niesters M, Swartjes M, Bauer M, Aarts L, Geleijnse N, Mooren R, Dahanl A, Sarton E. Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: a randomized, prospective, double blind, active placebo-controlled trial. Eur J Pain. 2011;15(9):942–9. doi:10.1016/j.ejpain.2011.03.008.
- Sleigh J, Harvey M, Voss L, Denny B. Ketamine – more mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care. 2014;4(2–3):76–81. doi:10.1016/j.tacc.2014.03.002.
- Iacobucci GJ, Visnjevac O, Pourafkari L, Nader ND. Ketamine: an update on cellular and subcellular mechanisms with implications for clinical practice. Pain Phys. 2017;20(2):E285–E301. doi:10.36076/ppj.2017.E301.
- Cohen SP, Bhatia A, Buvanendran A, et al. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):521–46. doi:10.1097/AAP.0000000000000808.
- Sigtermans MJ, et al. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain. 2009;145(3):304–11. doi:10.1016/j.pain.2009.06.023.
- Geisser ME, Roth RS, Theisen ME, Robinson ME, Riley JL. Negative affect, self-report of depressive symptoms, and clinical depression: relation to the experience of chronic pain. Clin J Pain. 2000;16(2):110–20. doi:10.1097/00002508-200006000-00004.
- Assouline B, Tramèr MR, Kreienbühl L, Elia N. Benefit and harm of adding ketamine to an opioid in a patient-controlled analgesia device for the control of postoperative pain: systematic review and meta-analyses of randomized controlled trials with trial sequential analyses. Pain. 2016;157(12):2854–64. doi:10.1097/j.pain.0000000000000705.
- McNicol ED, Ferguson MC, Hudcova J. Patient controlled opioid analgesia versus non-patient controlled opioid analgesia for postoperative pain. Cochrane Database Syst Rev. 2015, Issue 6. Art. No.: CD003348. doi:10.1002/14651858.CD003348.pub3.
- Romeo B, Choucha W, Fossati P, Rotge J-Y. Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression. Psychiatry Res. 2015;230(2):682–8. doi:10.1016/j.psychres.2015.10.032.
- Strasburger SE, Bhimani PM, Kaabe JH, Krysiak JT, Nanchanatt DL, Nguyen TN, Pough KA, Prince TA, Ramsey NS, Savsani KH, et al. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities . J Clin Pharm Ther. 2017;42(2):147–54. doi:10.1111/jcpt.12497.
- Lo TCT, Yeung ST, Lee S, Skavinski K, Liao S. Reduction of Central Neuropathic Pain with Ketamine Infusion in a Patient with Ehlers-Danlos syndrome: a case report. J Pain Res. 2016;9:683–7. doi:10.2147/jpr.s110261.
- Somashekara SC, Govindadas D, Devashankaraiah G, et al. Midazolam premedication in attenuating ketamine psychic sequelae. J Basic Clin Pharm. 2010;1(4):209–13.